4//SEC Filing
Biotest AG 4
Accession 0001193805-18-000697
CIK 0001368514other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:00 PM ET
Size
8.2 KB
Accession
0001193805-18-000697
Insider Transaction Report
Form 4
Biotest AG
Director10% Owner
Transactions
- Sale
Non-Voting Common Stock
2018-05-14−8,591,160→ 0 total(indirect: By Biotest Pharmaceuticals Corporation)
Holdings
- 10,109,534(indirect: By Biotest Pharmaceuticals Corporation)
Common Stock
Biotest Pharmaceuticals Corp
Director10% Owner
Transactions
- Sale
Non-Voting Common Stock
2018-05-14−8,591,160→ 0 total(indirect: By Biotest Pharmaceuticals Corporation)
Holdings
- 10,109,534(indirect: By Biotest Pharmaceuticals Corporation)
Common Stock
Footnotes (3)
- [F1]On May 14, 2018, pursuant to a Share Transfer, Amendment and Release Agreement, by and among, among other parties, the issuer, Biotest Pharmaceuticals Corporation ("BPC") and Biotest AG, BPC transferred to the issuer, for no cash consideration, 8,591,160 shares of the issuer's non-voting common stock previously issued to BPC in June 2017 and representing 100% of the issuer's then-issued and outstanding non-voting common stock.
- [F2]The shares were owned directly by BPC, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG.
- [F3]The shares are owned directly by BPC, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
IncorporatedGermany
Related Parties
1- filerCIK 0001709152
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:00 PM ET
- Size
- 8.2 KB